Joe Turk Named President for Fresenius Medical Care North America Renal Therapies Group

Fresenius Medical Care North America (FMCNA), the nation’s leading provider of kidney care products, announced today that Joseph (Joe) Turk has been named President for the company’s Renal Therapies Group.

In his new role, Joe Turk will be responsible for overseeing Renal Products and Pharmaceutical operations, including sales, clinical support, product marketing and management, customer and technical services, and regulatory affairs.

Having previously served as FMCNA’s President of Home and Critical Care Therapies, these expanded responsibilities align the company’s products teams into one organization – with a focus on efficiently and effectively delivering new technologies to support people living with kidney disease.

“Joe’s decades of strategy and market development experience have been critical in expanding our footprint and technologies in home dialysis and critical care since he joined us as part of the NxStage merger in 2019,” said Bill Valle, Chief Executive Officer, FMCNA. “Joe’s leadership will be instrumental as we focus on better leveraging best practices across divisions for the benefit of our customers, partners, field teams, and most importantly our patients.”

Turk succeeds Mark Costanzo, who recently retired as President of FMCNA’s Renal Therapies Group.

“I am thrilled to bring our exceptional teams together at this important time,” said Turk. “We have an incredible opportunity as the market leader to work together to ensure we’re providing the highest quality care and renal products to the patients we are privileged to serve.”

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy